SPEAKERS
Thank you to our distinguished speakers for their inspiring presentations throughout the years. Our diverse speakers are located across the U.S. and are selected by our Trudeau Society Steering Committee for their innovative research, best practices in patient care, and their immense work in improving lung health in our communities.
To inquire about becoming a speaker of Trudeau Society, please contact Paloma Ramos at pramos@breathesocal.org
Toby Maher, M.D.
Toby Maher, M.D., is Professor of Medicine and Director of Interstitial Lung Disease at Keck School of Medicine, University of Southern California, Los Angeles. He has spent the last 15 years specializing in the management of all forms of pulmonary fibrosis and orphan interstitial lung diseases.
He previously ran the ILD unit at Royal Brompton Hospital, London seeing more than 1500 new ILD patients per year. Since June 2020 he has been Director of ILD at Keck Medicine of USC. His research interests include; biomarker discovery, the lung microbiome and host immune response in the pathogenesis of IPF and clinical trials in interstitial lung disease. He has been involved in >50 trials in fibrotic lung disease from phase 1b through to phase 4 and including those assessing IPF, scleroderma, rheumatoid arthritis and inflammatory myositis. Overall, he has recruited > 1000 patients into interventional studies. He has given expert opinion to FDA and EMA. He is an associate editor for American Journal of Respiratory and Critical Care Medicine and has authored over 270 papers and book chapters on pulmonary fibrosis
Jonathan Corren, M.D.
Jonathan Corren, M.D., has been a faculty member in the departments of Medicine and Pediatrics at the David Geffen School of Medicine at the University of California, Los Angeles, since 1991 and is currently actively involved in allergy and immunology education at the university.
He is also medical director of a private practice in Allergy/Immunology and research director of a clinical research site which focusses upon severe asthma, chronic rhinosinusitis, allergy immunotherapy, immunodeficiencies, and allergic skin diseases.
He is currently project chair for a multi-center trial evaluating the immunologic and clinical effects of allergen-specific immunotherapy combined with an inhibitor of thymic stromic lymphopoietin. He is also a consultant regarding clinical study design with multiple pharmaceutical companies, including AstraZeneca, Genentech, Novartis, Regeneron, and Sanofi.
Guy W. Soo Hoo, MD, MPH
Dr. Soo Hoo is a Health Sciences Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA and is also the Acting Chief of the Pulmonary and Critical Care Section and Director, Pulmonary and Critical Care Unit at the West Los Angeles VA Healthcare Center.
He has been at the VA since 1989 and has a research interest in non-invasive ventilation, as well as non-pharmacologic treatment of Chronic Obstructive Pulmonary Disease. He is a Board member of BREATHE California of Los Angeles as well as past Chairman of the Board on two occasions. He has participated in World COPD day since its inception in 2010.
Dr. Soo Hoo has been involved with the care of patients with smoking related conditions during his entire professional career. More recently, he has collaborated on multisite investigations of patients with human immuno-deficiency virus (HIV) infection and effects on Chronic Obstructive Pulmonary Disease and lung cancer. In addition to academic investigations, he has also been involved with VA wide patient care projects in healthcare delivery, most recently in tele-spirometry programs and along with a comprehensive treatment program for patients with COPD including pulmonary rehabilitation, advanced bronchoscopic therapies and lung transplantation.
Jo Marie Reilly, MD MPH
Dr. Reilly is a Professor of Family Medicine at the Keck School of Medicine of USC (KSOM). She is the Director of the Keck School of Medicine of USC Primary Care Initiative, Associate Director of the KSOM Introduction to Clinical Medicine Course and KSOM Family Medicine Pre- Doctoral Director.
She graduated from Georgetown Medical School, completed her internship and residency in Family Medicine at the Kaiser Permanente Family Residency Program in Los Angeles and her fellowship in Women’s Health and Obstetrics at the White Memorial Family Practice Residency Program where she remained as faculty for 13 years.
She is the Chair of the American Academy of Family Physician’s commission on Education, Student and Resident Subcommittee, on the Editorial Boards of Family Medicine, Family Systems and Health and PULSE, the KSOM senior Family Medicine Student Advisor and on the leadership team of the Society of Teacher’s of Family Medicine’s Bioethics and Humanities Interest Group. Dr. Reilly’s publications and research interests include innovations in student and resident education, physician well-being, care for the underserved, arts, preventative medicine, humanities, narrative medicine, and women and children’s health care.
Brian Tiep, MD
Dr. Tiep is a seasoned pulmonologist who is distinguished amongst his peers and associates and has been the recipient of many prestigious awards and recognition throughout his celebrated career as a physician.
Dr. Tiep is the author of an immense body of peer reviewed original abstracts, articles, reviews and contributions in the area of pulmonary medicine. He has served on the Editorial Boards of respiratory journals and has presented various topics at scientific conferences, nationally and internationally. He has developed several patents in the area of oxygen therapy and developed the Respiratory Disease Management Institute and Pulmonary Rehabilitation programs that support the treatment and management of patients from post-acute care through end of life at City of Hope Medical Center.
Dr. Tiep has participated in leadership roles with many organizations and is well versed on the diagnosis, treatment and management of patients throughout the continuum of care.
Jeremy Falk, MD
Dr. Falk received his medical degree at the Ohio State University College of Medicine in 1998. He completed his residency, chief residency, and Pulmonary and Critical Care fellowship at Temple University.
He joined the faculty at Cedars-Sinai Medical Center in 2006. He currently serves as the Fellowship Program Director as well as the Associate Director of Lung Transplant. His clinical and research interests include pulmonary fibrosis, COPD, alpha-one antitrypsin deficiency and lung transplant.
Greg Lewis, M.D.
Dr. Lewis currently serves as Section Head of Heart Failure, Medical Director of the Heart Transplant Program, and Director of the Cardiopulmonary Exercise Testing Laboratory at Massachusetts General Hospital.
His research focuses on understanding functional limitations in patients with cardiopulmonary diseases by using exercise as a physiologic probe and evaluating novel therapies for heart failure and pulmonary hypertension with a particular focus on WHO Group 2 PH. He is particularly interested in the role of the lung circulation and other extra-cardiac organs in mediating exercise intolerance in heart failure with preserved ejection fraction. Through metabolic profiling of human plasma at rest and during exercise, in collaboration with the Broad Institute, his group has begun to establish metabolic signatures of cardiovascular disease states that may help to refine current phenotyping approaches. Dr. Lewis will highlight his extensive experience in utilizing comprehensive cardiopulmonary exercise testing for clinical evaluation of patients with dyspnea and mapping contributions of each organ system's contribution to reduced functional capacity.
Donald P. Tashkin, MD
Dr. Tashkin is Emeritus Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the David Geffen School of Medicine at the University of California Los Angeles (UCLA).
He previously served as Director of the Clinical Pulmonary Function Laboratory at the UCLA Medical Center for approximately 30 years. Dr. Tiep is the author of an immense body of peer reviewed original abstracts, articles, reviews and contributions in the area of pulmonary medicine. He has served on the Editorial Boards of respiratory journals and has presented various topics at scientific conferences, nationally and internationally. He has developed several patents in the area of oxygen therapy and developed the Respiratory Disease Management Institute and Pulmonary Rehabilitation programs that support the treatment and management of patients from post-acute care through end of life at City of Hope Medical Center.
Dr. Tiep has participated in leadership roles with many organizations and is well versed on the diagnosis, treatment and management of patients throughout the continuum of care.
Chris Cooper , MD
School of Medicine at UCLA where he is Director of the UCLA Exercise Physiology Research Laboratory. He is also a Global Medical Expert working with the Respiratory Franchise at GlaxoSmithKline.
He trained at the University of London, obtaining degrees in Physiology in 1973 and Medicine in 1976. In 1991, he obtained an additional Doctoral degree for his thesis on pulmonary rehabilitation and in 2013 he obtained a Master’s degree in Clinical Research with a focus on Biomathematics and Epidemiology.
He moved to UCLA as a Fulbright Scholar in 1987 to pursue research interests in exercise physiology. In 2009, he received the prestigious Sherman M. Mellinkoff Faculty Award, the highest faculty distinction awarded by the David Geffen School of Medicine at UCLA. Dr. Cooper has 30 years of experience in basic and applied exercise physiology as well as COPD and asthma research. He has published and lectured extensively on exercise physiology as well as the pathophysiology of COPD and pulmonary rehabilitation. He is author of a popular book entitled “Exercise testing and interpretation: A practical approach.”
Harry Rossiter, PhD
Dr. Rossiter is an Associate Professor at the David Geffen School of Medicine at UCLA, and a Fellow of the American College of Sports Medicine. He received a PhD in Physiology from the University of London, and completed postdoctoral training in Pulmonary Physiology at the University of California San Diego.
Dr. Rossiter is a member of the Editorial Boards of Journal of Applied Physiology, Experimental Physiology and European Journal of Applied Physiology. Dr. Rossiter conducts clinical and translational research in respiratory medicine, focusing on Chronic Obstructive Pulmonary Disease, at the Rehabilitation Clinical Trials Center at the Los Angeles Biomedical Research Institute (Harbor-UCLA Medical Center).
William W. Stringer, MD
Dr. Stringer graduated from the University of California, San Diego with a BA in Biochemistry. He completed his MD at UCSD in 1984 and performed his Internal Medicine Internship, Residency, Chief Medical Residency, and Pulmonary/Critical Care Fellowship at Harbor-UCLA Medical Center in Torrance, California.
He is currently a Professor of Medicine at the Geffen School of Medicine at UCLA and previously was the Chairman of the Department of Internal Medicine at Harbor UCLA Medical Center.
He is active in medical teaching, patient care, research, information systems, and admin-istrative activities at Harbor. His research interests include cardiopulmonary exercise testing and pharmacologic interventions in chronic obstructive pulmonary disease.
Zab B. Mosenifar, MD
Dr. Mosenifar is a Geri and Richard Brawerman Professor of Medicine and Executive Vice Chairman of the Department of Medicine. He is also the Medical Director of Women’s Guild Lung Institute at Cedars-Sinai Medical Center and David Geffen School of Medicine at UCLA.
He received his Medicine and Pulmonary training at New Jersey College of Medicine, University of Thomas Jefferson in Philadelphia and University of California in Los Angeles respectively.
Dr. Mosenifar has received many grants and has been serving on the editorial board of a number of prestigious Journals including CHEST and COPD and Intensive Care Medicine. He is Editor-in-Chief of the pulmonary section for Medscape. He was one of the Principal Investigators of National Emphysema Treatment Trial, sponsored by the National Heart, Lung and Blood Institute as well as the Health Care Financing Administration which compared lung volume reduction surgery versus medical therapy in patients with emphysema. Dr. Mosenifar is an internationally recognized expert in treatment of asthma, COPD and has authored more than 200 articles, reviews, book chapters, abstracts. Most recently he edited a two volume text book entitled “Practical Pulmonary and Critical Care Medicine.”
George Chaux, MD
Dr. Chaux is Board certified in Internal Medicine, and has specialized certification in Pulmonary and in Critical Care Medicine. His primary areas of research and clinical interest involve state-of-the-art diagnosis, treatment and post-operative management strategies for lung transplant patients and individuals with pulmonary arterial hypertension and idiopathic pulmonary fibrosis.
In addition, he is actively involved in developing the interventional pulmonology program at Cedars-Sinai Medical Center which includes the advanced use of rigid bronchoscopy with laser treatment of airway tumors, stenting of airway strictures and the introduction of new technologies such as SuperDimension for the biopsy of peripheral lung lesions and endobronchial ultrasound for the biopsy of mediastinal lymph nodes.
Dr. Chaux received his Bachelor’s degree from Bowdoin College in Brunswick, Maine and his medical degree from Boston University School of Medicine. At the University of California, San Diego Medical Center, he completed an internship and residency in Internal medicine, serving as Chief Resident, and a fellowship in Pulmonary and Critical Care Medicine. He also served as Medical Director of the Lung and Heart-Lung Transplant Program at UCSD following his training and before coming to Cedars-Sinai Medical Center.
Reza Ronaghi, MD
Medical Board Certifications
Internal Medicine, American Board of Internal Medicine, 2015 Pulmonary Disease, American Board of Internal Medicine, 2018 Critical Care Medicine, American Board of Internal Medicine, 2019
Fellowship
Pulmonary & Critical Care Medicine, LAC+USC Medical Center, 2016-2019
Residency
Chief Resident, UCSF-Fresno Medical Education Program, 2015-2016
Internal Medicine, UCSF-Fresno Medical Education Program, 2012-2015
Degree
Saba University School of Medicine, MD, 2012
Presentation Topics
Trudeau Society speakers present on a variety of topics, take a look at a few of our remarkable speakers and discussion topics through the years below: